Dana Goldman, PhD


Formulary Restrictions and Stroke Risk in Patients With Atrial Fibrillation

August 04, 2022

Limiting access to non–vitamin K antagonist oral anticoagulants through step therapy and prior authorization may exacerbate current underuse of anticoagulants and increase the risk of stroke in patients with newly diagnosed atrial fibrillation.

The Long-term Social Value of Granulocyte Colony-Stimulating Factors

October 04, 2019

Although currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would increase this value considerably.